Evaluating CMR

Assessing CVD Risk: Traditional Approaches

Others

References

Page: Go to Previous Page 9 of 9 Go to Next Page
  1. Giampaoli S, Palmieri L, Mattiello A, et al. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases. Nutr Metab Cardiovasc Dis 2005; 15: 79-85.
  2. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998; 19: 1434-503.
  3. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
  4. Assmann G, Cullen P and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 2002; 105: 310-5.
  5. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003.
  6. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin Sci (Lond) 2001; 101: 671-9.
  7. Ferrario M, Chiodini P, Chambless LE, et al. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005; 34: 413-21.
  8. Vartiainen E, Jousilahti P, Alfthan G, et al. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000; 29: 49-56.
  9. Bjartveit K, Foss OP, Gjervig T, et al. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979; 634: 1-70.
  10. Njolstad I, Arnesen E and Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996; 93: 450-6.
  11. Shaper AG, Pocock SJ, Walker M, et al. British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns. Br Med J (Clin Res Ed) 1981; 283: 179-86.
  12. Tunstall-Pedoe H, Woodward M, Tavendale R, et al. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ 1997; 315: 722-9.
  13. Schroll M, Jorgensen T and Ingerslev J. The Glostrup Population Studies, 1964-1992. Dan Med Bull 1992; 39: 204-7.
  14. Wilhelmsen L, Berglund G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986; 7: 279-88.
  15. Keil U, Liese AD, Hense HW, et al. Classical risk factors and their impact on incident non-fatal and fatal myocardial infarction and all-cause mortality in southern Germany. Results from the MONICA Augsburg cohort study 1984-1992. Monitoring Trends and Determinants in Cardiovascular Diseases. Eur Heart J 1998; 19: 1197-207.
  16. Ducimetiere P, Richard JL, Cambien F, et al. Coronary heart disease in middle-aged Frenchmen. Comparisons between Paris Prospective Study, Seven Countries Study, and Pooling Project. Lancet 1980; 1: 1346-50.
  17. Rodes A, Sans S, Balana LL, et al. Recruitment methods and differences in early, late and non-respondents in the first MONICA-Catalonia population survey. Rev Epidemiol Sante Publique 1990; 38: 447-53.
  18. Collaborative US-USSR study on the prevalence of dyslipoproteinemias and ischemic heart disease in American and Soviet populations. Prepared by the US-USSR Steering Committee for Problem Area 1: the pathogenesis of atherosclerosis. Am J Cardiol 1977; 40: 260-8.
  19. Regional differences in dietary habits, coronary risk factors and mortality rates in Belgium. 1. Design and methodology. Nutrition and health: an interuniversity study. Acta Cardiol 1984; 39: 285-92.
  20. Presentation of the rifle project risk factors and life expectancy. The RIFLE Research Group. Eur J Epidemiol 1993; 9: 459-76.
  21. Sans Menendez S, Tomas Abadal L and Domingo Salvany A. Estudio de prevention multifactorial de la cardiopatia isquemica. Intervention sobre factores de riesgo coronario en una poblacion industrial. Resultados de los dos primeros anos. Rev San Hig Publ 1981; 55: 555-70.
  22. Sans Menendez S. Ensayo randomizado de prevention multifactorial de la cardiopatia isquemica. PhD doctoral dissertation. Bellaterra: Publications of the Autonomous University of Barcelona. 1994.
  23. Fuller JH, Stevens LK and Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 Suppl 2: S54-64.
  24. Barrett-Connor EL, Cohn BA, Wingard DL, et al. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991; 265: 627-31.
  25. Koskinen P, Manttari M, Manninen V, et al. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992; 15: 820-5.
  26. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141-7.
  27. Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
  28. McEwan P, Williams JE, Griffiths JD, et al. Evaluating the performance of the Framingham risk equations in a population with diabetes. Diabet Med 2004; 21: 318-23.
  29. The UK Prospective Diabetes Study. http://www.dtu.ox.ac.uk/index.php?maindoc=/ukpds/, last accessed in August 2007.
  30. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
  31. Thomas EL, Brynes AE, McCarthy J, et al. Preferential loss of visceral fat following aerobic exercise, measured by magnetic resonance imaging. Lipids 2000; 35: 769-76.
  32. Khaw KT, Wareham N, Luben R, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001; 322: 15-8.
  33. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.
  34. Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med 1984; 76: 4-12.
  35. The National register of coronary and cerebrovascular events. Ital Heart J 2004; 5 (suppl.3): 22s-37s.
  36. The Italian cardiovascular epidemiological observatory. Ital Heart J 2004; 5 (Suppl. 3): 49s-92s.
  37. Avins AL and Neuhaus JM. Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med 2000; 160: 1937-44.
Page: Go to Previous Page 9 of 9 Go to Next Page
Print this document